Skip to main content

Advertisement

Log in

Breast cancer prognostic markers in the post-genomic era

  • Invited Commentary
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

The Original Article was published on 30 March 2010

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Pusztai L, Leyland-Jones B (2008) Promises and caveats of in-silico biomarker discovery. Br J Cancer 99:385–386

    Article  CAS  PubMed  Google Scholar 

  2. Gyorffy B, Lanczky A, Eklund AC et al (2010) An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1809 patients. Breast Cancer Res Treat. doi:10.1007/s10549-009-0674-9

  3. Greenbaum D, Colangelo C, Williams K et al. (2003) Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol 4: 117–117.8

    Google Scholar 

  4. Lu P, Vogel C, Wang R et al (2007) Absolute protein expression profiling estimates the relative contributions of transcriptional and translational regulation. Nat Biotechnol 25:117–124

    Article  CAS  PubMed  Google Scholar 

  5. Schmidt M, Hasenclever D, Schaeffer M et al (2008) Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer. Clin Cancer Res 14:5849–5855

    Article  CAS  PubMed  Google Scholar 

  6. Andre F, Hatzis C, Anderson K et al (2007) Microtubule-associated protein-tau is a bifunctional predictor of endocrine sensitivity and chemotherapy resistance in estrogen receptor-positive breast cancer. Clin Cancer Res 13:2061–2067

    Article  CAS  PubMed  Google Scholar 

  7. Iwamoto T, Bianchini G, Coutant C et al (2009) Different biological processes are associated with prognosis and chemotherapy sensitivity in the different molecular subtypes of breast cancer. Cancer Res 69(Suppl):864s (Abs 6124)

    Article  Google Scholar 

  8. Schmidt M, Scheulie ME, Dittrich C et al (2010) An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer. Ann Oncol 21:275–282

    Article  CAS  PubMed  Google Scholar 

  9. Simon RM, Paik S, Hayes DF (2009) Use of archived specimens in evaluation of prognostic and predictive biomarkers. J Natl Cancer Inst 101:1446–1452

    Article  PubMed  Google Scholar 

  10. Sotiriou C, Pusztai L (2009) Gene-expression signatures in breast cancer. N Engl J Med 360:790–800

    Article  CAS  PubMed  Google Scholar 

  11. Wirapati P, Sotiriou C, Kunkel S, Farmer et al (2008) Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures. Breast Cancer Res 10:R65

    Article  PubMed  Google Scholar 

  12. Yu JX, Sieuwerts AM, Zhang Y et al (2007) Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer. BMC Genomics 7:182. doi:10.1186/1471-2407-7-182

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lajos Pusztai.

Additional information

This is an invited commentary to article doi:10.1007/s10549-010-0856-5.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pusztai, L., Iwamoto, T. Breast cancer prognostic markers in the post-genomic era. Breast Cancer Res Treat 125, 647–650 (2011). https://doi.org/10.1007/s10549-010-0932-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-010-0932-x

Keywords

Navigation